Literature DB >> 25394386

Prognostic significance of metastatic lymph node number, ratio and station in gastric neuroendocrine carcinoma.

Xiaolong Tang1, Yingtai Chen, Lanwei Guo, Jianwei Zhang, Chengfeng Wang.   

Abstract

The objective of this study was to analyze the prognostic significance of metastatic lymph node status in gastric neuroendocrine carcinoma (GNEC) patients following radical gastrectomy. A consecutive series of 73 patients who underwent gastrectomy between 1999 and 2011 for GNEC was retrospectively reviewed. Indexes of lymph node involvement (the pN classification, metastatic lymph node number [MLNn], ratio [MLNr], and station [MLNs]) and other clinicopathological data were analyzed. Fifty-four patients met the inclusion criteria and were enrolled in the study. Among them, 44 patients (81 %) were found to have lymph node metastases. The median survival time of the entire cohort was 63.2 (range, 14-153) months with 3- and 5-year survival rates of 88.9 and 47.9 %, respectively. The median total number of lymph nodes, MLNn, and MLNr were 19 (range, 10-56), 5 (range, 1-21), and 25 % (6-100 %), respectively. Cox regression analysis revealed pN classification = 1, MLNn >2, MLNr >0.1, and MLNs = 2, and distant metastases influenced prognosis independently (P = 0.0266, 0.0091, 0.0031, 0.0119, and 0.0021, respectively). In addition to the pN classification, indexes of metastatic lymph node involvement, including MLNn, MLNr, and MLNs, were all significant predictors of survival in GNEC patients. Distant metastasis was also a significant prognostic factor. These indexes proved to be accurate and important supplements to survival factors, which may improve risk classification of GNEC patients.

Entities:  

Mesh:

Year:  2014        PMID: 25394386     DOI: 10.1007/s11605-014-2691-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  Evaluation of lymph node metastasis in patients with gastric cancer: a comparison of the directionality of lymph node metastasis and the total number of metastatic lymph nodes.

Authors:  Maki Kitagawa; Daisuke Ichikawa; Shuhei Komatsu; Kazuma Okamoto; Atsushi Shiozaki; Hitoshi Fujiwara; Yasutoshi Murayama; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Toshiya Ochiai; Yukihito Kokuba; Teruhisa Sonoyama; Eigo Otsuji
Journal:  Surg Today       Date:  2012-12-12       Impact factor: 2.549

2.  Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis.

Authors:  Skye C Mayo; Mechteld C de Jong; Carlo Pulitano; Brian M Clary; Srinevas K Reddy; T Clark Gamblin; Scott A Celinksi; David A Kooby; Charles A Staley; Jayme B Stokes; Carrie K Chu; Alessandro Ferrero; Richard D Schulick; Michael A Choti; Giles Mentha; Jennifer Strub; Todd W Bauer; Reid B Adams; Luca Aldrighetti; Lorenzo Capussotti; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2010-06-29       Impact factor: 5.344

3.  Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.

Authors:  Mary K G McStay; Dave Maudgil; Martin Williams; Jonathan M Tibballs; Anthony F Watkinson; Martyn E Caplin; John R Buscombe
Journal:  Radiology       Date:  2005-09-28       Impact factor: 11.105

4.  Long-term survival after surgical management of neuroendocrine hepatic metastases.

Authors:  Evan S Glazer; Jennifer F Tseng; Waddah Al-Refaie; Carmen C Solorzano; Ping Liu; Katherine A Willborn; Eddie K Abdalla; Jean-Nicolas Vauthey; Steven A Curley
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

5.  Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers.

Authors:  Paolo Massucco; Dario Ribero; Enrico Sgotto; Alfredo Mellano; Andrea Muratore; Lorenzo Capussotti
Journal:  Ann Surg Oncol       Date:  2009-09-24       Impact factor: 5.344

6.  Comparison of four staging systems of lymph node metastasis in gastric cancer.

Authors:  Ming Zhang; Guanyu Zhu; Yan Ma; Yingwei Xue
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

7.  The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.

Authors:  Alberto Marchet; Simone Mocellin; Alessandro Ambrosi; Paolo Morgagni; Domenico Garcea; Daniele Marrelli; Franco Roviello; Giovanni de Manzoni; Annamaria Minicozzi; Giovanni Natalini; Francesco De Santis; Luca Baiocchi; Arianna Coniglio; Donato Nitti
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

8.  Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease.

Authors:  A Frilling; J Li; E Malamutmann; K-W Schmid; A Bockisch; C E Broelsch
Journal:  Br J Surg       Date:  2009-02       Impact factor: 6.939

9.  Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas.

Authors:  Paweł Gut; Jakub Fischbach; Grzegorz Kamiński; Marek Ruchała
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20

10.  Clinical implications of metastatic lymph node ratio in gastric cancer.

Authors:  Caigang Liu; Ping Lu; Yang Lu; Huimian Xu; Shubao Wang; Junqing Chen
Journal:  BMC Cancer       Date:  2007-10-24       Impact factor: 4.430

View more
  7 in total

1.  Further Classification for Node-Positive Gastric Neuroendocrine Neoplasms.

Authors:  Linda M Pak; Tingsong Yang; Jiping Wang
Journal:  J Gastrointest Surg       Date:  2018-06-27       Impact factor: 3.452

2.  Risk factors associated with splenic hilar lymph node metastasis in patients with advanced gastric cancer in northwest China.

Authors:  Zhenqiang Sun; Qisan Wang; Xianbo Yu; Chunlin Ou; Lizhong Yao; Kun Liu; Lin Liu; Lei Ge; Fa Fang; Zeliang Zhao; Haijiang Wang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Value of computed tomography evaluation in pathologic classification and prognosis prediction of gastric neuroendocrine tumors.

Authors:  Shida Yan; Tongtong Liu; Ying Li; Yongjian Zhu; Jun Jiang; Liming Jiang; Hong Zhao
Journal:  Ann Transl Med       Date:  2019-10

4.  Deaths of colon neuroendocrine tumors are associated with increasing metastatic lymph nodes and lymph node ratio.

Authors:  Changchun Xiao; Baorong Song; Peipei Yi; Yangyang Xie; Biqing Li; Peng Lian; Shaoqing Ding; Yuanming Lu
Journal:  J Gastrointest Oncol       Date:  2020-12

5.  Gastric neuroendocrine neoplasias: manifestations and comparative outcomes.

Authors:  S Felder; H Jann; R Arsenic; T Denecke; V Prasad; B Knappe-Drzikova; S Maasberg; B Wiedenmann; M Pavel; A Pascher; U F Pape
Journal:  Endocr Relat Cancer       Date:  2019-09       Impact factor: 5.678

6.  Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study.

Authors:  Xianghui Li; Lihua Shao; Xiaofeng Lu; Zhengyang Yang; Shichao Ai; Feng Sun; Meng Wang; Wenxian Guan; Song Liu
Journal:  BMC Surg       Date:  2021-03-31       Impact factor: 2.102

Review 7.  New Developments in Gastric Neuroendocrine Neoplasms.

Authors:  Klaire Exarchou; Nathan A Stephens; Andrew R Moore; Nathan R Howes; D Mark Pritchard
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.